| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.0058 | 1 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.0055 | 1 |